Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
MicroStrategy moves forward with a bold plan to reach 1 million BTC by 2026, backed by a multi-billion-dollar financi...
A Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
Nuclear energy is attracting new attention from investors. This guide compares NuScale Power and Constellation Energy...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
NVIDIA leads the AI hardware wave while Palantir gains momentum on enterprise software. Investors debate which stock ...
Savvy savers in their 40s are increasingly splitting 401K contributions between traditional and Roth accounts to bala...
A $225 million merger unites Major League Pickleball with Carvana's PPA Tour, forming Pickleball Inc. and signaling a...
Coinbase announced a 14% workforce cut to accelerate a lean, AI-native operating model amid ongoing crypto market vol...
Zcash jumped about 40% in a single session, signaling a renewed push for privacy-focused assets as institutions eye h...
As gold holds its bid in a backdrop of steady inflation, the iShares Gold Trust SPDR comparison centers on a 0.15% an...